A Hybrid Structure-Based Machine Learning Approach for Predicting Kinase Inhibition by Small Molecules.

Journal: Journal of chemical information and modeling
Published Date:

Abstract

Kinases have been the focus of drug discovery programs for three decades leading to over 70 therapeutic kinase inhibitors and biophysical affinity measurements for over 130,000 kinase-compound pairs. Nonetheless, the precise target spectrum for many kinases remains only partly understood. In this study, we describe a computational approach to unlocking qualitative and quantitative kinome-wide binding measurements for structure-based machine learning. Our study has three components: (i) a Kinase Inhibitor Complex (KinCo) data set comprising predicted kinase structures paired with experimental binding constants, (ii) a machine learning loss function that integrates qualitative and quantitative data for model training, and (iii) a structure-based machine learning model trained on KinCo. We show that our approach outperforms methods trained on crystal structures alone in predicting binary and quantitative kinase-compound interaction affinities; relative to structure-free methods, our approach also captures known kinase biochemistry and more successfully generalizes to distant kinase sequences and compound scaffolds.

Authors

  • Changchang Liu
    Laboratory of Systems Pharmacology, Department of Systems Biology, Harvard Program in Therapeutic Science, Harvard Medical School, Boston, MA 02115, USA.
  • Peter Kutchukian
    Novartis Institutes for Biomedical Research, Cambridge, Massachusetts 02139, United States.
  • Nhan D Nguyen
    Pritzker School of Molecular Engineering, University of Chicago, Chicago, Illinois 60637, United States.
  • Mohammed AlQuraishi
    Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA 02115, USA; Department of Systems Biology, Harvard Medical School, Boston, MA 02115, USA. Electronic address: alquraishi@hms.harvard.edu.
  • Peter K Sorger
    Laboratory of Systems Pharmacology, Harvard Medical School, Boston, MA, USA peter_sorger@hms.harvard.edu.